Keryx Biopharmaceuticals (KERX) Announces The Closing Of The Acquisition Of ACCESS Oncology Inc.
10/19/2005 5:09:56 PM
More...
|
Keryx Biopharmaceuticals (KERX) Adds Three Clinical-Stage Oncology Drug Candidates To Its Pipeline, Including A Novel, First-In-Class, Oral AKT-Inhibitor In Phase II
10/19/2005 5:09:38 PM
More...
|